CHM
CHIMERIC THERAPEUTICS LIMITED
$0.0030
0.00%
Suspended
Market cap
—
Turnover
—
Last price
$0.0030
Day change
0.00%
Announcements
12
Range, past year
Open 0.003 · Low 0.001 · Now 0.003 · High 0.200
Open CHM in the full dashboard →
Charts, screener, momentum and signals across every ASX-listed code.
CHM momentum and trend analysis
Our analysis
Independent analysis generated by Stock Trade Intelligence
as at 2026-10-13.
Trend stage
Neutral
1 Day
+0.0%
1 Week
+0.0%
1 Month
-57.1%
RSI
27
Avg daily range
45.7%
CHIMERIC THERAPEUTICS LIMITED is currently suspended from quotation and last traded on 30 Sep 2026. The momentum, trend and cycle figures below are frozen at that session rather than describing the market today, and the price above is its last traded price.
Browse the whole market by signal:
ASX stocks in Wyckoff accumulationASX momentum stocks by trend qualityASX stocks breaking outASX stocks near 52-week highsCHM announcements
Recent price-sensitive releases.
- 2026-10-01 Suspension from Quotation Suspension from Official Quotation
- 2026-08-31 Appendix 4E and Preliminary Final Report Preliminary Final Report
- 2026-08-19 CHM ceases enrolment in Phase 1 trial and Company update Notification of Results/Reporting Date | Trading Halt Lifted | Progress Report
- 2026-08-17 Trading Halt Trading Halt
- 2026-07-31 Quarterly Activities/Appendix 4C Cash Flow Report Commitments Test Entity - Fourth Quarter Activity Report | Web Cast | Commitments Test Entity - Fourth Quarter Cashflow Report
- 2026-07-29 Chimeric receives $1.62M advance on FY26 R&D tax incentive Progress Report | Debt Facility
- 2026-07-16 CHM CDH17 Phase 1 clinical trial update - New DL 3 data
More Health Care stocks
Most traded in the same sector.